No Data
Cirrus (02507.HK): Appointment of Liu Zhongwen as Chief Independent Non-Executive Director
Cirrus (02507.HK) announced that the board has appointed Liu Zhongwen, the current independent non-executive director, chairman of the Audit, Risk, and Compliance Committee, and member of the Remuneration Committee, to serve as the Chief Independent Non-Executive Director, effective from December 5, 2025.
HK Stock Movement | Cirrus (02507) Surges Over 4% Again Following Inclusion in MSCI Global Small Cap Index; Earnings Growth Expected to Accelerate
Cirrus (02507) rose more than 4% again. As of the time of writing, it was up 4.45%, trading at HKD 49.28 with a turnover of HKD 10.4751 million.
MSCI Global Small Cap Index Rebalancing: 22 Stocks Including Ascletis Pharma (01672) and Chabaidao (02555) Added
On November 6, MSCI announced the results of its November index review. The adjustments will take effect after the market close on November 24.
Cirrus (02507.HK) subsidiary renews and extends the warranty protection agreement with Continental until the end of 2026.
Gelonghui, November 3rd丨Cirrus (02507.HK) announced a connected transaction regarding Cirrus Design (a wholly-owned subsidiary of the company) purchasing extended warranty coverage from Continental.
Hong Kong Stock Movement | Cirrus (02507) Rises Nearly 6% Amid Favorable Developments in the Low-Altitude Economy; Institutions Express Confidence in Its Long-Term Steady Growth Potential
Cirrus (02507) rose nearly 6%. As of the time of writing, it was up 5.98%, trading at HKD 54.05, with a turnover of HKD 21.1299 million.
CIRRUS: Interim Report 2025